Skip to content
Dx

HCPCS Level II · Procedures and professional services (temporary)

G9071Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About G9071

G9071 is an HCPCS Level II code in the G series (procedures and professional services (temporary)), describing oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project).

It was added to HCPCS effective 01/01/2006, and its current record took effect 01/01/2007.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Onc dx brst stg1-2b hr,nopro
Date added
01/01/2006
Action effective
01/01/2007
BETOS
P7B

Related G90xx codes

Common questions about G9071

Is HCPCS G9071 still valid?

Yes. G9071 is active in the CMS October 2026 HCPCS file.

Does Medicare cover G9071?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.